Creating healthcare access is not about “squeezing the existing structure,” rather, it requires flipping the script on what access looks like, according to Jefferson Health President Baligh Yehia, MD. Jefferson Health is a Philadelphia-based, 33-hospital system with a lofty goal. “When…
Author: Paige Twenter
In early March, the American Cancer Society named Tyler Jacks, PhD, the recipient of its 2026 medal of honor, its most prestigious award. Dr. Jacks is president of Break Through Cancer, a nonprofit initiative that unites U.S. cancer institutes to…
Use of GLP-1 medications was associated with lower long-term mortality among patients with colorectal cancer and obesity, according to research presented at an oncology conference. Over a 10-year period, GLP-1 drugs were associated with about 5.6 fewer deaths per 100…
Mark Cuban Cost Plus Drug Co. has added Vegzelma, a biosimilar indicated for six cancer types, to its marketplace for hospitals and other healthcare providers. The company plans to expand its biosimilar offerings amid growing demand for biologics among health…
West Orange, N.J.-based RWJBarnabas and Rutgers Cancer Institute in New Brunswick, N.J., are joining to expand access to oncology specialty care services. The two organizations are working together to add oncology specialty services at University Hospital, a 519-bed academic medical…
Advertisement
Although lung cancer incidence rates are declining, more young and middle-age women are being diagnosed at higher rates than men, CNN reported Nov. 25.
From 2012 to 2021, breast cancer incidence has risen 1%, with steep increases among young women and Asian American/Pacific Islander women, according to the American Cancer Society.
Double mastectomies have similar survival rates to lumpectomies and single mastectomies, according to research published July 25 in JAMA Oncology.
The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer.
Substance use disorders are highly variable among cancer patient populations, and new research points to five cancers with the highest prevalence of SUDs, according to a study published Jan. 11 in JAMA.